Dysregulation of PI3K/Akt/mTOR pathway is frequently reported in B-ALL [103] and correlates with worse prognosis and chemo-resistance in pediatric B-ALL patients [15]. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.